Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00739635
Study type Interventional
Source Merz Pharmaceuticals GmbH
Contact
Status Completed
Phase Phase 3
Start date September 2008
Completion date February 2010

See also
  Status Clinical Trial Phase
Completed NCT00955799 - Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT03550430 - Neurofeedback for Tinnitus - Does Frequency Specificity Matter? N/A
Completed NCT00772980 - Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus Phase 3
Completed NCT04829214 - OTO-313 in Subjects With Unilateral Subjective Tinnitus Phase 2
Completed NCT01268449 - Evaluation of Low Dose Laser in Treatment of Tinnitus Phase 2
Completed NCT01177137 - Tinnitus Retraining Therapy Trial Phase 3
Terminated NCT00827008 - Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00567892 - Collaborative Tinnitus Research at Washington University Phase 2
Unknown status NCT00555776 - Effect of Gabapentin on Idiopathic Subjective Tinnitus Phase 2
Completed NCT05265949 - The Effects of Weight Loss on Tinnitus Symptoms N/A
Completed NCT04696588 - Neck Kinesiotherapy and Massage in Tinnitus Treatment N/A